Efek Ekstrak Etanolik Daun Sirsak pada Proliferasi dan Apoptosis Sel HeLa yang Dimediasi oleh p53

Authors

  • Ermin Rachmawati Departemen Fisiologi Fakultas Kedokteran Universitas Lampung Bandar Lampung
  • Setyawati Karyono Laboratorium Farmakologi Fakultas Kedokteran Universitas Brawijaya Malang
  • Hidayat Suyuti Laboratorium Biokimia-Biomolekuler Fakultas Kedokteran Universitas Brawijaya Malang

DOI:

https://doi.org/10.21776/ub.jkb.2012.027.01.5

Abstract

Kanker  serviks  merupakan  penyebab  utama  kedua  kematian  kanker  pada wanita  di seluruh  dunia, menyebabkan  240.000 kematian  setiap  tahunnya.  Ekstrak  daun  Annona  muricata  berpotensi  baik  sebagai  obat  anti  kanker .  T ujuan  dari  penelitian ini  adalah  untuk  mengetahui  pengaruh  ekstrak  etanol  daun  sirsak  (Annona  muricata)  dalam  menghambat  dan menginduksi  aktivasi apoptosis yang dimediasi oleh stabilisasi p53 pada pertumbuhan kanker serviks.  Sebuah percobaan in vitro dilakukan dengan menggunakan kultur sel HeLa. Penghambatan proliferasi diukur dengan MTT assay. Apoptosis dideteksi  dengan  menggunakan  flowcytometry  Annexin  V  Biotin  Kit  Apoptosis  Detection.  Konfirmasi  dan  perhitungan ekspresi  p53  ditentukan  oleh  imunocytochemistry.  Ekstrak  etanol  dari  daun  Annona muricata  secara  efektif  menghambat proliferasi sel HeLa dengan dosis tertentu pada paparan 48 jam. Nilai  IC50 ekstrak etanol daun Annona muricata adalah 111,75  ug/ml.  200  mg/ml  ekstrak  menginduksi  apoptosis  sel  HeLa  tergantung  dari  lama  pemaparan.  Ekstrak  ini  juga meningkatkan  ekspresi  p53  sel  HeLa  tergantung  dosis  pemberian  (25,  50,  100,  200  μg/ml)  dan  lama  pemberian  (24  dan  48 jam).  Dapat  disimpulkan  bahwa  ekstrak  etanol  daun  sirsak  menghambat  pertumbuhan  sel  HeLa  dan  menginduksi apoptosis.  Mekanisme  ekstrak  daun  sirsak  menghambat  proliferasi  dan  apoptosis  inducing  berhubungan  dengan stabilisasi  dan  aktivasi  p53.Kata  Kunci:  Daun  Annona  muricata,  apoptosis,  ekstrak  etanol,  proliferasi,  ekspresi  p53

Downloads

Download data is not yet available.

References

Liao JB. Viruses and Human Cancer. Yale Journal of Biology and Medicine. 2006; 79: 115-122.

Chakrabarti O and Krishna S. Molecular Interaction of High Risk Human Papillomavirus E6 and E7 Oncoproteins: Implications for Tumor Progression. Journal of Biosciences. 2003; 28(3): 337-348.

Phelps WC, Yee CL, Munger K and Howley PM. The Human Papillomavirus Type 16 E7 Gene Encodes Transactivation and Transforming Functions Similar to Adenovirus E1A. Cell. 1988; 53(4): 539-547.

Scheffner M, Huibregtse JM, Vierstra R and Howley PM. The HPV-16 E6 and E6-AP Complex Functions as a Ubiquitin-protein Ligase in the Ubiquitination of p53. Cell. 1993; 75: 495–505.

SchmittE, Paquet C, Beauchemin M, and Bertrand R. Review: DNA-damage Response Network at the Crossroads of Cell Cycle Checkpoints, Cellular Senescence and Apoptosis. Journal of Zhejiang University Science B. 2007; 8(6): 377-397.

Borges HL, Chao C, Xu Y, Linden R and Wang JYJ. Radiaton-Induced Apoptosis in Developing Mouse Retina Exhibits Dose Dependent Requirement for ATM Phosporylation of p53. Cell Death and Differentiation. 2004; 11(5): 494-502.

Kim MK, KimTJ, Sung C, Choi CH, Lee J, and Bae D. Clinical Significance of HIF-2α Immunostaining Area in Radioresistant Cervical Cancer. Journal of Gynecologic Oncology. 2011; 22(1): 144-148.

LiK, LiQ, Han Z, Li J, Gao D, Liu Z and Zheng F. Alkaloid from Angelicae Dahuricae Inhibits Hela Cell Growth by Inducing Apoptosis and Increasing Caspase-3 Activity. LabMedicine. 2008; 39(9): 540-546.

Kim TJ, Lee J, Song SY, Choi J, Kim BG, Lee J and Bae DS. Increased Expression of Pakt is Associated with Radiation Resistance in Cervical Cancer. British Journal of Cancer. 2006; 94: 1678-1682.

Alali FQ, Liu XX, and McLaughlin JL. Annonaceous Acetogenins: Recent Progress. Journal of Natural Product. 1999; 62(3): 504–540.

Betancur-Galvis LA, Saez J, Granados H, Salazar A, and Ossa JE. Antitumor and Antiviral Activity of Colombian Medicinal Plant Extracts. Memórias do Instituto Oswaldo Cruz. 1999; 94(4): 531-535.

Yuan SF, Chang H, Chen H, et al. Annonacin, a Mono-tetrahydrofuran Acetogenin, Arrests Cancer Cells at the G1 Phase and Causes Cytotoxicity in a Bax- and Caspase-3-related Pathway. Life Sciences. 2003; 72: 2853-2861.

Oberlies NH, Croy VL, Harrison ML, and McLaughin JR. The Annonaceous Acetogenin Bullatacin is Cytotoxic Against Multidrug Resistant Human Mammary Adenocarcinoma (MCF-7/Adr) Cells. Cancer Letters. 1997; 115: 73-79

Degli EM, Ghelli A, Ratta M, Cortes D, and Estornell E. Natural Substances (Acetogenins) from the Family Annonaceae are Powerful Inhibitors of Mitochondrial NADH Dehydrogenase (Complex I). Biochemical Journal. 1994; 301(1): 161–167.

Zafra-Polo MC, Gonzalez MC, Estornell E, Sahpaz S, and Cortes D. Acetogenins from Annonaceae, Inhibitors of Mitochondrial Complex I. Phytochemistry. 1996;42(2): 253–271.

Trubus. Daun Sirsak versus Kemoterapi. Jakarta; PT. Trubus Swadaya; 2011; hal. 15.

Lodish H, Berk A, Zipursky SL, Matsudaira P, and Darnell Y. Molecular Cell Biology. 5th edition. New York: WH Freeman & Company; 2003.

Elmore S. A Review of Programmed Cell Death. Toxicologic Pathology. 2007; 35(4): 495-516.

Poon IKH, Hulett MD and Parish CR. Molecular Mechanism of Late Apoptotic Cleareance. Cell Death and Differentiation. 2010; 17: 381-397.

Sakaguchi K, Herrera JE, Saito S, et al. DNA Damage Activates p53 through a Phosphorylation–acetylation Cascade. Science. 1998; 281: 1677–1679

Shaulsky G, Ben-Zeev A, and Rotter V. Subcellular Distribution of the p53 Protein during the Cell Cycle of Balb/c 3T3 Cells. Oncogene. 1990; 5: 1707–1711.

Liebermann DA, Hoffman B, and Vesely D. p53 Induced Growth Arrest versus Apoptosis and its Modulation by Survival Cytokine. Cell Cycle. 2006; 2(2): 166-170.

Kastan MB, Zhan Q, El-Deiry WS, et al. A Mammalian Cell Cycle Checkpoint Pathway Utilizing p53 and GADD45 is Defective in Ataxia-telangiectasia. Cell. 1992; 71: 587-597.

Polyak K, Xia Y, and Zweier JL. A Model for p53-induced Apoptosis. Nature. 1997; 389: 300–305.

Bellamy COC. p53 and Apoptosis. British Medical Bulletin. 1997; 53(3): 522-538.

Sionov RV and Haupt Y. The Cellular Response to p53: the Decision between Life and Death. Oncogene. 1999; 18: 6145-6157.

Downloads

Published

2013-04-25

Issue

Vol. 27 No. 1 (2012)

Section

Research Article

License

Authors who publish with this journal agree to the following terms:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).